全文获取类型
收费全文 | 1282篇 |
免费 | 34篇 |
出版年
2023年 | 3篇 |
2022年 | 11篇 |
2021年 | 11篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 14篇 |
2017年 | 19篇 |
2016年 | 25篇 |
2015年 | 31篇 |
2014年 | 44篇 |
2013年 | 73篇 |
2012年 | 87篇 |
2011年 | 92篇 |
2010年 | 60篇 |
2009年 | 45篇 |
2008年 | 70篇 |
2007年 | 77篇 |
2006年 | 96篇 |
2005年 | 87篇 |
2004年 | 79篇 |
2003年 | 84篇 |
2002年 | 81篇 |
2001年 | 21篇 |
2000年 | 7篇 |
1999年 | 10篇 |
1998年 | 19篇 |
1997年 | 9篇 |
1996年 | 11篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1993年 | 6篇 |
1991年 | 9篇 |
1990年 | 5篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1978年 | 8篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1970年 | 4篇 |
1966年 | 2篇 |
1956年 | 2篇 |
排序方式: 共有1316条查询结果,搜索用时 46 毫秒
111.
Przewloka MR Venkei Z Bolanos-Garcia VM Debski J Dadlez M Glover DM 《Current biology : CB》2011,21(5):399-405
Centromeres provide a region of chromatin upon which kinetochores are assembled in mitosis. Centromeric protein C (CENP-C) is a core component of this centromeric chromatin that, when depleted, prevents the proper formation of both centromeres and kinetochores. CENP-C localizes to centromeres throughout the cell cycle via its C-terminal part, whereas its N-terminal part appears necessary for recruitment of some but not all components of the Mis12 complex of the kinetochore. We now find that all kinetochore proteins belonging to the KMN (KNL1/Spc105, the Mis12 complex, and the Ndc80 complex) network bind to the N-terminal part of Drosophila CENP-C. Moreover, we show that the Mis12 complex component Nnf1 interacts directly with CENP-C in vitro. To test whether CENP-C's N-terminal part was sufficient to recruit KMN proteins, we targeted it to the centrosome by fusing it to a domain of Plk4 kinase. The Mis12 and Ndc80 complexes and Spc105 protein were then all recruited to centrosomes at the expense of centromeres, leading to mitotic abnormalities typical of cells with defective kinetochores. Thus, the N-terminal part of Drosophila CENP-C is sufficient to recruit core kinetochore components and acts as the principal linkage between centromere and kinetochore during mitosis. 相似文献
112.
Birkenfeld AL Lee HY Guebre-Egziabher F Alves TC Jurczak MJ Jornayvaz FR Zhang D Hsiao JJ Martin-Montalvo A Fischer-Rosinsky A Spranger J Pfeiffer AF Jordan J Fromm MF König J Lieske S Carmean CM Frederick DW Weismann D Knauf F Irusta PM De Cabo R Helfand SL Samuel VT Shulman GI 《Cell metabolism》2011,14(2):184-195
Reduced expression of the Indy (I'm Not Dead, Yet) gene in D.?melanogaster and its homolog in C.?elegans prolongs life span and in D.?melanogaster augments mitochondrial biogenesis in a manner akin to caloric restriction. However, the cellular mechanism by which Indy does this is unknown. Here, we report on the knockout mouse model of the mammalian Indy (mIndy) homolog, SLC13A5. Deletion of mIndy in mice (mINDY(-/-) mice) reduces hepatocellular ATP/ADP ratio, activates hepatic AMPK, induces PGC-1α, inhibits ACC-2, and reduces SREBP-1c levels. This signaling network promotes hepatic mitochondrial biogenesis, lipid oxidation, and energy expenditure and attenuates hepatic de novo lipogenesis. Together, these traits protect mINDY(-/-) mice from the adiposity and insulin resistance that evolve with high-fat feeding and aging. Our studies demonstrate a profound effect of mIndy on mammalian energy metabolism and suggest that mINDY might be a therapeutic target for the treatment of obesity and type 2 diabetes. 相似文献
113.
Many biological and clinical outcomes are based not on single proteins, but on modules of proteins embedded in protein networks. A fundamental question is how the proteins within each module contribute to the overall module activity. Here, we study the modules underlying three representative biological programs related to tissue development, breast cancer metastasis, or progression of brain cancer, respectively. For each case we apply a new method, called Network-Guided Forests, to identify predictive modules together with logic functions which tie the activity of each module to the activity of its component genes. The resulting modules implement a diverse repertoire of decision logic which cannot be captured using the simple approximations suggested in previous work such as gene summation or subtraction. We show that in cancer, certain combinations of oncogenes and tumor suppressors exert competing forces on the system, suggesting that medical genetics should move beyond cataloguing individual cancer genes to cataloguing their combinatorial logic. 相似文献
114.
Brozek I Cybulska C Ratajska M Piatkowska M Kluska A Balabas A Dabrowska M Nowakowska D Niwinska A Pamula-Pilat J Tecza K Pekala W Rembowska J Nowicka K Mosor M Januszkiewicz-Lewandowska D Rachtan J Grzybowska E Nowak J Steffen J Limon J 《Journal of applied genetics》2011,52(3):325-330
The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5) mutations of the BRCA1 gene were performed on a group of respectively 16,849, 13,462, 12,485 and 3923 anonymous samples collected at birth in seven Polish provinces. The patient group consisted of 1845 consecutive female breast cancer cases. The most frequent BRCA1 mutation in the general population was 5382insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respectively 11 of 13,462 (0.08%) and four of 3923 (0.1%) samples. The population prevalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer cases were, respectively, 1.9% (35/1845) and 1.2% (18/1486). Comparing these data with the population frequency, we calculated the relative risk of breast cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on large population studies, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general population. Carriage of one of these mutations is connected with a very high relative risk of breast cancer. 相似文献
115.
116.
117.
118.
Janusz Winiecki Zbigniew ?urawski Barbara Drzewiecka Krzysztof ?losarek 《Reports of Practical Oncology and Radiotherapy》2011,16(1):1-9
Background
During a proper execution of dMLC plans, there occurs an undesired but frequent effect of the dose locally accumulated by tissue being significantly different than expected. The conventional dosimetric QA procedures give only a partial picture of the quality of IMRT treatment, because their solely quantitative outcomes usually correspond more to the total area of the detector than the actually irradiated volume.Aim
The aim of this investigation was to develop a procedure of dynamic plans verification which would be able to visualize the potential anomalies of dose distribution and specify which tissue they exactly refer to.Materials & methods
The paper presents a method discovered and clinically examined in our department. It is based on a Gamma Evaluation concept and allows accurate localization of deviations between predicted and acquired dose distributions, which were registered by portal as well as film dosimetry. All the calculations were performed on the self-made software GammaEval, the γ-images (2-dimensional distribution of γ-values) and γ-histograms were created as quantitative outcomes of verification.Results
Over 150 maps of dose distribution have been analyzed and the cross-examination of the gamma images with DRRs was performed.Conclusions
It seems, that the complex monitoring of treatment would be possible owing to the images obtained as a cross-examination of γ-images and corresponding DRRs. 相似文献119.
120.